PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
July 19, 2007Journal of the American Society of Nephrology337 citations

The Glomerular Injury of Preeclampsia

View Full Paper
ISIsaac E. StillmanSKS. Ananth Karumanchi

Key Points

Key points are not available for this paper at this time.

Abstract

Central α4βδ receptors are the most abundant isoform of δ subunit–containing extrasynaptic GABAA receptors that mediate tonic inhibition. Although the amplitude of GABA-activated currents through α4βδ receptors is modulated by multiple general anesthetics, the effects of general anesthetics on desensitization and deactivation of α4βδ receptors remain unknown. In the current study, we investigated the effect of etomidate, a potent general anesthetic, on the kinetics and the pseudo steady-state current amplitude of α4β3δ receptors inducibly expressed in human embryonic kidney 293 TetR cells. Etomidate directly activates α4β3δ receptors in a concentration-dependent manner. Etomidate at a clinically relevant concentration (3.2 μM) enhances maximal response without altering the EC50 of GABA concentration response. Etomidate also increases the extent of desensitization and prolongs the deactivation of α4β3δ receptors in the presence of maximally activating concentrations of GABA (1 mM). To mimic the modulatory effect of etomidate on tonic currents, long pulses (30–60 seconds) of a low GABA concentration (1 μM) were applied to activate α4β3δ receptors in the absence and presence of etomidate. Although etomidate increases the desensitization of α4β3δ receptors, the pseudo steady-state current amplitude at 1 μM GABA is augmented by etomidate. Our data demonstrate that etomidate enhances the pseudo steady-state current of α4β3δ receptors evoked by a GABA concentration comparable to an ambient GABA level, suggesting that α4β3δ receptors may mediate etomidate’s anesthetic effect in the brain.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Stillman et al. (2007) studied this question.

synapsesocial.com/papers/6a5b619034b9ec96ca129c02https://doi.org/10.1681/asn.2007020255
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Neutralization of Circulating Vascular Endothelial Growth Factor (VEGF) by Anti-VEGF Antibodies and Soluble VEGF Receptor 1 (sFlt-1) Induces Proteinuria2003 · 535 citations
  2. 2Elevated levels of vascular endothelial growth factor in serum of patients with D+ HUS2004 · 22 citations
  3. 3Circulating angiogenic factors and the risk of preeclampsia*2004 · 2,623 citations
  4. 4Preeclamptic nephropathy. An electron microscopic study.1962 · 45 citations
  5. 5Early onset pre-eclampsia: recognition of underlying renal disease.1987 · 80 citations